| Serial Number | 98377390 |
| Word Mark | ADVANCED MEDICINE PARTNERS |
| Filing Date | Friday, January 26, 2024 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Tuesday, August 20, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Manufacture for others of pharmaceuticals; manufacture for others of products relating to biotechnology; manufacture for others of cell therapy products; manufacture for others of gene therapy products; pharmaceutical manufacturing in accordance with GMP regulations |
| Description of Mark | The mark consists of a design suggestive of a vertically oriented chromosome with an electrical bolt forming the junction between the two halves and the words ADVANCED MEDICINE PARTNERS arranged in descending order immediately to the right of the design. |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Contract development and manufacturing organization (CDMO) services; consulting and advisory services in the field of analytical development and quality control testing of pharmaceutical, gene therapy, and cell therapy products; consulting and advisory services in the field of manufacturing process development for pharmaceutical, gene therapy and cell therapy products; consulting in the field of chemistry manufacturing and controls (CMC) activities; testing of pharmaceutical, gene therapy, and cell therapy products and materials; quality control testing of pharmaceutical products and materials; testing and validation services for pharmaceutical, cell therapy and gene therapy methods of development; technical consulting for regulatory compliance in the field of chemistry manufacturing and controls (CMC) |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 26, 2024 |
| Primary Code | 040 |
| First Use Anywhere Date | Monday, October 2, 2023 |
| First Use In Commerce Date | Monday, October 2, 2023 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 26, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, October 2, 2023 |
| First Use In Commerce Date | Monday, October 2, 2023 |
| Party Name | JAGUAR GENE THERAPY, LLC |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | LAKE FOREST, IL 60045 |
| Party Name | Advanced Medicine Partners, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Lake Forest, IL 60045 |
| Event Date | Event Description |
| Friday, January 26, 2024 | NEW APPLICATION ENTERED |
| Monday, July 29, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, July 29, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, August 12, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, August 20, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, August 20, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, August 20, 2024 | NON-FINAL ACTION E-MAILED |
| Friday, November 15, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Friday, November 15, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Wednesday, February 5, 2025 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |